Cystinuria News

Partial correction of cystinuria type A in mice via kidney-targeted transposon delivery We used kidney-targeted, non-viral, transposon-mediated gene delivery to express the mouse Slc3a1 transgene in one kidney of cystinuria type A (Slc3a1−/−) mice. [...]

Non-viral gene therapy to treat cystinuria Aug. 4, 2025 Original Story  (Unfortunately the story is buried behind a paywall so we may need to wait for the study to be published before [...]

Cystinuria Pipeline Insight 2025: Redefining Treatment through Precision Therapies and Rare Disease Innovation | DelveInsight Original Story 07-21-2025 04:20 PM CET | Health & Medicine Press release from: DelveInsight DelveInsight's "Cystinuria - Pipeline Insight, [...]

Cystinuria Pipeline Insight 2025: Redefining Treatment through Precision Therapies and Rare Disease Innovation | DelveInsight Original Story Professor Richard Coward from the University of Bristol has received a Kidney Research UK research project grant of £230,000 to [...]

“Go big or go small”: Current and emerging tools in kidney stone management Original Story Key Takeaways Recent advancements in kidney stone management include novel access sheaths and miniaturized scopes, enhancing treatment [...]

Sexual Dimorphism in Cystinuria- The Mitochondria Link Original Story Unravelling the role of mitochondrial Slc3a1 in regulating mitochondrial functions and sexual dimorphism in cystinuria CHINA, March 28, 2025 /EINPresswire.com/ -- Cystinuria is the most [...]

New US product launch, VENXXIVA™ (tiopronin) Delayed-Release Tablets for the treatment of cystinuria Original Story BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) announced today the launch of VENXXIVA (tiopronin) Delayed-Release Tablets, for the treatment [...]

Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria Original Story PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company [...]

Cystinuria-Related Urinary Stone as the Cause of Repeated Urinary Tract Infections (UTIs) in a Child Original Story Abstract Urinary tract infections (UTIs) are one of the most common bacterial infections in children [...]

EAU Updates Urinary Stone Guidelines Original Story The European Association of Urology (EAU) has updated its urolithiasis guidelines to  reflect scientific evidence that has emerged during the last 8 years. The panel [...]

Challenges in diagnosis and treatment of cystinuria patients with Urolithiasis: multicenter patient centered study. Original Story Cystinuria represents a rare cause of urolithiasis, accounting for 1% of all cases. However, it poses [...]

Cystinuria drugs in development, 2024 Original Story The Cystinuria drugs in development market research report provides comprehensive information on the therapeutics under development for Cystinuria, complete with analysis by stage of development, [...]